Search research articles
Contact Us
Filters
Showing results (451-460 of 566) with videos related to
Page
of 57
Sort By:
Research Square
|
July 9, 2025
Ultra-Processed Food Intake is Associated with Altered Glucose Homeostasis in Young Adults
Yiping Li, Elizabeth Costello, Sarah Rock, et al.
Cell Death & Disease
|
August 17, 2019
Inhibition of IRE1α RNase activity reduces NLRP3 inflammasome assembly and processing of pro-IL1β
Aaron Talty, Shane Deegan, Mila Ljujic, et al.
CPT: Pharmacometrics & Systems Pharmacology
|
December 30, 2016
Population Pharmacokinetics Modeling of Unbound Efavirenz, Atazanavir, and Ritonavir in HIV-Infected Subjects With Aging Biomarkers
J B Dumond, J Chen, M Cottrell, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)
|
December 16, 2014
Immunologic, virologic, and pharmacologic characterization of the female upper genital tract in HIV-infected women
Lisa Rahangdale, Kristina De Paris, Angela D M Kashuba, et al.
Science (New York, N.Y.)
|
August 30, 2014
Thyroid hormone-dependent adult pigment cell lineage and pattern in zebrafish
Sarah K McMenamin, Emily J Bain, Anna E McCann, et al.
Plos One
|
April 13, 2012
Modification of Ad5 hexon hypervariable regions circumvents pre-existing Ad5 neutralizing antibodies and induces protective immune responses
Joseph T Bruder, Elena Semenova, Ping Chen, et al.
Gut Microbes
|
August 23, 2021
Early life gut microbiota is associated with rapid infant growth in Hispanics from Southern California
Tanya L Alderete, Roshonda B Jones, Justin P Shaffer, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)
|
February 5, 2010
Phase I/II trial of the anti-HIV activity of mifepristone in HIV-infected subjects ACTG 5200
Michael F Para, Jeff Schouten, Susan L Rosenkranz, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)
|
April 28, 2006
Lopinavir/ritonavir induces the hepatic activity of cytochrome P450 enzymes CYP2C9, CYP2C19, and CYP1A2 but inhibits the hepatic and intestinal activity of CYP3A as measured by a phenotyping drug cocktail in healthy volunteers
Rosa F Yeh, Vincent E Gaver, Kristine B Patterson, et al.
Molecular Cancer Therapeutics
|
April 14, 2005
Tumor penetration of gefitinib (Iressa), an epidermal growth factor receptor tyrosine kinase inhibitor
David McKillop, Elizabeth A Partridge, John V Kemp, et al.
Page
of 57
Search research articles
Search
Showing results (451-460 of 566) with videos related to
Sort By:
Page
of 57
Research Square
|
July 9, 2025
Ultra-Processed Food Intake is Associated with Altered Glucose Homeostasis in Young Adults
Yiping Li, Elizabeth Costello, Sarah Rock, et al.
Cell Death & Disease
|
August 17, 2019
Inhibition of IRE1α RNase activity reduces NLRP3 inflammasome assembly and processing of pro-IL1β
Aaron Talty, Shane Deegan, Mila Ljujic, et al.
CPT: Pharmacometrics & Systems Pharmacology
|
December 30, 2016
Population Pharmacokinetics Modeling of Unbound Efavirenz, Atazanavir, and Ritonavir in HIV-Infected Subjects With Aging Biomarkers
J B Dumond, J Chen, M Cottrell, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)
|
December 16, 2014
Immunologic, virologic, and pharmacologic characterization of the female upper genital tract in HIV-infected women
Lisa Rahangdale, Kristina De Paris, Angela D M Kashuba, et al.
Science (New York, N.Y.)
|
August 30, 2014
Thyroid hormone-dependent adult pigment cell lineage and pattern in zebrafish
Sarah K McMenamin, Emily J Bain, Anna E McCann, et al.
Plos One
|
April 13, 2012
Modification of Ad5 hexon hypervariable regions circumvents pre-existing Ad5 neutralizing antibodies and induces protective immune responses
Joseph T Bruder, Elena Semenova, Ping Chen, et al.
Gut Microbes
|
August 23, 2021
Early life gut microbiota is associated with rapid infant growth in Hispanics from Southern California
Tanya L Alderete, Roshonda B Jones, Justin P Shaffer, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)
|
February 5, 2010
Phase I/II trial of the anti-HIV activity of mifepristone in HIV-infected subjects ACTG 5200
Michael F Para, Jeff Schouten, Susan L Rosenkranz, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)
|
April 28, 2006
Lopinavir/ritonavir induces the hepatic activity of cytochrome P450 enzymes CYP2C9, CYP2C19, and CYP1A2 but inhibits the hepatic and intestinal activity of CYP3A as measured by a phenotyping drug cocktail in healthy volunteers
Rosa F Yeh, Vincent E Gaver, Kristine B Patterson, et al.
Molecular Cancer Therapeutics
|
April 14, 2005
Tumor penetration of gefitinib (Iressa), an epidermal growth factor receptor tyrosine kinase inhibitor
David McKillop, Elizabeth A Partridge, John V Kemp, et al.
Page
of 57